CCL21 and T-cell non-Hodgkin lymphoma: CCL19 and CCL21 have been reported to have the same efficacy and potency in G protein activation (in H9 T cell lymphoma cells) (19) and Ca2+ flux (in L1.2 cells, a murine pre-B cell line) (57).